the aid library

LIST OPTIONS

Filter

5382

Primeiras medidas para gestão de um surto de diarreia aguda

World Health Organization (2010) C_WHO

The document provides guidelines for the prevention and control of cholera outbreaks. It focuses on key strategies such as improving access to safe drinking water, ensuring proper sanitation, and promoting hygiene practices to prevent the spread of the disease. The guidelines also emphasize the impo... more

External Link

Prevención y control del cólera

Centers for Disease Control and Prevention CDC (2018) C2

The document titled "Prevención y control del cólera" (Cholera Prevention and Control) provides essential guidance on preventing and managing cholera, a disease characterized by severe watery diarrhea and vomiting. Without prompt treatment, cholera can lead to death due to dehydration within hours... more

Download (1378)

View PDF (3522)

First steps for managing an outbreak of acute diarrhoea - Arabic version
recommended

World Health Organization (2010) C_WHO

Download (1522)

View PDF (2803)

Hatua za kwanza zinazotakiwa kuchukua kwenye mlipuko mkali wa magonjwa ya kuhara

World Health Organization (2010) C_WHO

Download (145)

View PDF (175)

Первоочедны е меры контроля вспышки остро й диареи

World Health Organization (2010) C_WHO

The document provides guidance on managing acute diarrhoea outbreaks, specifically cholera and shigellosis. It outlines steps for identifying outbreaks, differentiating between cholera and shigellosis, and treating patients based on the severity of dehydration. Recommendations include the use of ora... more

Download (1039)

View PDF (2024)

Primeros pasos para controlar un brote de diarrea aguda

World Health Organization (2010) C_WHO

External Link

External Link (151)

Clinical Features of Malaria

Centers for Disease Control and Prevention (CDC) (2025) C2

The CDC webpage on the clinical features of malaria outlines the disease's presentation, categorizing it into uncomplicated and severe forms, and emphasizes that prompt and accurate diagnosis and treatment can lead to a cure.

Download (809)

View PDF (1978)

Prevansyon kont diare

Organización Panamericana de la Salud (2016) C2

The document "Prevansyon kont Diare" provides guidance on preventing and managing diarrhea. It explains that diarrhea, caused by pathogens like viruses, bacteria, and parasites, can lead to severe dehydration if untreated. Symptoms include vomiting, fever, and loss of appetite, with severe cases req... more

Download (580)

View PDF (833)

Evidence of the risks and benefits of vaccinating pregnant women with WHO pre-qualified cholera vaccines during mass campaigns

Global Task Force on Cholera Control (GTFCC) World Health Organisation (WHO) (2016) C_WHO

The technical note from the Global Task Force on Cholera Control (GTFCC) examines the risks and benefits of vaccinating pregnant women with WHO-prequalified oral cholera vaccines (OCVs) during mass vaccination campaigns. It highlights that three WHO-approved vaccines (Dukoral®, Shanchol™, and Euv... more

Download (364)

View PDF (412)

Vamos proteger-nos da cólera

UNICEF (2019) C_UNICEF

The PDF "Vamos proteger-nos da Cólera" provides comprehensive guidance on cholera prevention and response strategies, particularly for use in community health settings. It emphasizes the importance of safe water use by treating water with bleach, boiling it for at least 5 minutes, or using purifica... more

Download (434)

View PDF (971)

Yemen: Humanitarian Snapshot - Children’s situation in Yemen (October 2017). Arabic Version

UN Office for the Coordination of Humanitarian Affairs (2017) C1

The document presents a humanitarian snapshot from October 2017 highlighting the dire situation of children in Yemen. Over 11 million Yemeni children needed humanitarian assistance due to the conflict that began in March 2015. The report shows one child dying every 10 minutes from preventable causes... more

Download (345)

View PDF (456)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (381)

View PDF (426)

Community Engagement During Public Health Emergencies Like COVID-19: An Action Framework and Toolkit

Bangladesh Red Crescent Society; BRAC; Government of Bangladesh; UN Children's Fund UNICEF; UN Women; World Health Organization WHO (2023) CC

This handbook offers a simple framework of action for actors in local government, and in particular, health leaders such as Civil Surgeons (CSs) and Upazila Health and Family Planning Officers (UHFPQOs), to take ownership and leadership to combat COVID-19 at each district and upazila respectively, w... more

Download (1080)

View PDF (2724)

Management of pneumonia in community settings
recommended

World Health Organization (2004)

Download (1367)

View PDF (4714)

Standard precautions in health care

World Health Organization (2007) C_WHO

Download (242)

View PDF (283)

Уборка и дезинфекция помещений и поверхностей в контексте COVID-19

World Health Organization WHO (2020) C_WHO

Цель настоящего документа - дать указания по очистке и дезинфекции поверхностей окружающей среды в контексте КОВИД-19. Настоящее руководство предназначено для раб�... more